Proton pump inhibitor failure: Why does it occur and how can it be managed?

Digestion

Volumn 73, Issue 4, 2006, Pages 215-217

  Savarino, Vincenzo ^a   Savarino, Edoardo ^a   Dulbecco, Pietro ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C19; PROTON PUMP INHIBITOR;

DOSE TIME EFFECT RELATION; DRUG TREATMENT FAILURE; EDITORIAL; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; PRIORITY JOURNAL;

ENZYME INHIBITORS; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; PROTON PUMPS; TREATMENT OUTCOME;

EID: 33748990090     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094788     Document Type: Editorial

References (21)

1. Savarino V, Dulbecco P: Optimizing symptom relief and preventing complications in adults with gastro-oesophageal reflux disease. Digestion 2004;69(Suppl 1):9-16.
2. Sgouros SN, Mantides A: Refractory heart-burn to proton pump inhibitors: epidemiology, aetiology and management. Digestion 2006;73:218-227.
3. Hungin AP, Rubin G, O'Flanagan H: Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 1999;49:463-464.
4. Gunaratnam NT, Jessup TP, Inadomi J, Lascewski DP: Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006;23:1473-1477.
5. Fass R, Shapiro M, Dekel R, Sewell J: Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next? Aliment Pharmacol Ther 2005;22:79-94.
6. Frazzoni M, De Micheli E, Grisendi A, Savarino V: Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression. Aliment Pharmacol Ther 2002;16:881-886.
7. Vela M, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO: Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001;120:1599-1606.
8. Martinez SD, Malagon IB, Garewall HS, Cui H, Fass R: Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003;17:537-545.
9. Tack J, Koek G, Demedts I, Sifrim D, Janssens J: Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 2004;99:981-988.
10. Schenk BE, Kuipers EJ, Klinkeberg-Knol EC, Eskes SA, Meuwissen SG: Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999;94:884-887.
11. Caraco Y, Wilkinson GR, Wood AJ: Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole. Clin Pharmacol Ther 1996;60:396-404.
12. Tutuian R, Katz PO, Castell DO: Nocturnal acid breakthrough: pH, drugs and bugs. Eur J Gastroenterol Hepatol 2004;16:441-443.
13. Nzeako UC, Murray JA: An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy. Aliment Pharmacol Ther 2002;16:1309-1316.
14. Watson RG, Tham TC, Johnston BT, McDougall NI: Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the 'sensitive oesophagus'. Gut 1997;40:587-590.
15. Wo JM, Mendez C, Harrell S, Joubran R, Bressoud PF, McKinney WP: Clinical impact of upper endoscopy in the management of patients with gastroesophageal reflux disease. Am J Gastroenterol 2004;99:2311-2316.
16. Charbel S, Khanwala F, Vaezi MF: The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005;100:283-289.
17. des Varannes SB, Mion F, Ducrottè P, Zerbib F, Denis P, Ponchon T, Thibault R, Galmiche JP: Simultaneous recording of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 2005;54:1682-1686.
18. Zentilin P, Dulbecco P, Savarino E, Giannini E, Savarino V: Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastrooesophageal reflux (literature review). Dig Liver Dis 2004;36:565-569.
19. Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, Castell D: Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy. A multicentre study using combined ambulatory impedance-pH monitoring. Gut DOI: 10.1136/gut.2005.087668.
20. Mainie I, Castell D: Do we need to rethink fundoplication for patients who have failed PPI therapy ? Nat Clin Pract Gastroenterol Hepatol 2006;3:2-3.
21. Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Tan S, DeMeester SR, Hagen JA, Bremner CG: Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999;3:292-300.